![Paul A. Barsanti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul A. Barsanti
Chief Tech/Sci/R&D Officer at
IDEAYA BIOSCIENCES, INC.
Profile
Paul A. Barsanti is Chief Technology Officer at IDEAYA Biosciences, Inc. since 2023.
Formerly, Dr. Barsanti was Head-Chemistry at Nurix Therapeutics, Inc. from 2014 to 2018.
Education includes an undergraduate degree conferred in 1993 and a doctorate conferred in 1996, both from the University of Bath.
Paul A. Barsanti active positions
| Companies | Position | Start |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 28/02/2023 |
Former positions of Paul A. Barsanti
| Companies | Position | End |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Corporate Officer/Principal | 31/05/2018 |
Training of Paul A. Barsanti
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Paul A. Barsanti
